New research has shown that neuroendocrine tumors are more
common than previously thought. Progress in our understanding of
the molecular pathogenesis of these not-so-rare cancers has
resulted in renewed interest in developinginnovative therapeutic
options. In particular, novel molecular targeted agents have been
shown to have significant anti-tumor activity, and integration of
these therapies has led to critical advances in management.
In this volume, an outstanding group of the world s leaders in
the field have assembled to convey their knowledge of the
epidemiology, biology, and management of allthemajor types of
neuroendocrine tumors. The book takes a multi-modality approach to
understanding disease processes and therapeutics, including
chapters on medical and surgical treatment as well as a chapter
devoted to imaging. Throughout, the authors emphasize recent
advances in our understanding of molecular biology and the
subsequent emerging therapeutic options.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!